The risks of smoking in patients with spondyloarthritides

Annals of the Rheumatic Diseases

Volumn 71, Issue 6, 2012, Pages 791-792

  Braun, Jürgen ^a   Sieper, Joachim ^b   Zink, Angela ^c  

^a RHEUMAZENTRUM RUHRGEBIET   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c German Rheumatism Research Centre   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

ADVERSE OUTCOME; ANKYLOSING SPONDYLITIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CROHN DISEASE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; EDITORIAL; HUMAN; INCIDENCE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; QUALITY OF LIFE; RISK ASSESSMENT; SMOKING; SPONDYLARTHRITIS;

ARTHRITIS, PSORIATIC; FEMALE; HEALTH STATUS; HUMANS; MALE; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SMOKING; SPONDYLITIS, ANKYLOSING;

EID: 84860914925     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200954     Document Type: Editorial

References (33)

1. Bogdanovica I, Godfrey F, McNeill A, et al. Smoking prevalence in the European Union: a comparison of national and transnational prevalence survey methods and results. Tob Control 2011;20:e4.
2. Davis S, Malarcher A, Thorne S, et al. Statespecific prevalence and trends in adult cigarette smoking - United States, 1998-2007. Morb Mortal Wkly Rep 2009;58:221-6.
3. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011;378:1297-305.
4. Mähönen MS, McElduff P, Dobson AJ, et al. Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations. Tob Control 2004;13:244-50. (Pubitemid 39451992)
5. Doll R, Peto R, Boreham J, et al. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004;328:1519.
6. Pomerleau OF. Nicotine and the central nervous system: biobehavioral effects of cigarette smoking. Am J Med 1992;93:2S-7S.
7. He LP, Tang XY, Ling WH, et al. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies. Heart 2010;96:339-46.
8. Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-32. (Pubitemid 40365093)
9. Krause D, Schleusser B, Herborn G, et al. Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000;43:14-21. (Pubitemid 30368208)
10. Dixon WG, Watson KD, Lunt M, et al. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum 2007;56:2905-12. (Pubitemid 47502736)
11. Sugiyama D, Nishimura K, Tamaki K, et al. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 2010;69:70-81.
12. Westhoff G, Rau R, Zink A. Rheumatoid arthritis patients who smoke have a higher need for DMARDs and feel worse, but they do not have more joint damage than non-smokers of the same serological group. Rheumatology (Oxford) 2008;47:849-54. (Pubitemid 351796371)
13. Stolt P, Bengtsson C, Nordmark B, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis 2003;62:835-41. (Pubitemid 37026493)
14. Carlens C, Hergens MP, Grunewald J, et al. Smoking, use of moist snuff, and risk of chronic inflammatory diseases. Am J Respir Crit Care Med 2010;181:1217-22.
15. Chung HY, Machado P, van der Heijde D, et al. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis. Published Online First: 11 Oct 2011. doi:10.1136/annrheumdis-2011-200180.
16. Li W, Han J, Qureshi AA. Smoking and risk of incident psoriatic arthritis in US women. Ann Rheum Dis Published Online First: 8 Nov 2011. doi:10.1136/annrheumdis-2011-200416
17. Poddubnyy D, Haibel H, Listing J, et al. Baseline radiographic damage, elevated acute phase reactants and cigarette smoking status predict radiographic progression in the spine in early axial spondyloarthritis. Arthritis Rheum. Published Online First: 29 Nov 2011. doi:10.1002/art.33465.
18. Eder L, Shanmugarajah S, Thavaneswaran A, et al. The association between smoking and the development of psoriatic arthritis among psoriasis patients. Ann Rheum Dis 2011;71:219-24.
19. Han C, Robinson DW Jr, Hackett MV, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2006;33:2167-72. (Pubitemid 44749774)
20. Mathieu S, Gossec L, Dougados M, et al. Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2011;63:557-63.
21. Hollan I, Saatvedt K, Almdahl SM, et al. Spondyloarthritis: a strong predictor of early coronary artery bypass grafting. Scand J Rheumatol 2008;37:18-22.
22. Averns HL, Oxtoby J, Taylor HG, et al. Smoking and outcome in ankylosing spondylitis. Scand J Rheumatol 1996;25:138-42. (Pubitemid 26180272)
23. Doran MF, Brophy S, MacKay K, et al. Predictors of longterm outcome in ankylosing spondylitis. J Rheumatol 2003;30:316-20. (Pubitemid 36152597)
24. Ward MM, Hendrey MR, Malley JD, et al. Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis. Arthritis Rheum 2009;61:859-66.
25. Ward MM, Weisman MH, Davis JC Jr, et al. Risk factors for functional limitations in patients with long-standing ankylosing spondylitis. Arthritis Rheum 2005;53:710-17. (Pubitemid 41463836)
26. Mattey DL, Dawson SR, Healey EL, et al. Relationship Between Smoking and Patient-reported Measures of Disease Outcome in Ankylosing Spondylitis. J Rheumatol 2011;38:2608-15.
27. Love TJ, Qureshi AA, Karlson EW, et al. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol 2011;147:419-24.
28. Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med 2007;120:953-9. (Pubitemid 350011082)
29. Tey HL, Ee HL, Tan AS, et al. Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis. J Dermatol 2010;37:426-30.
30. Jamnitski A, Visman IM, Peters MJ, et al. Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis. Ann Rheum Dis 2011;70:875-6.
31. Fiore M, Baker TB. Treating smokers in the health care settting. N Engl J Med 2011;365:1222-31.
32. Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. Aliment Pharmacol Ther 2005;21:921-31. (Pubitemid 40529727)
33. Peters MJ, Symmons DP, McCarey D, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010;69:325-31.